Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1

2(50.0%)

N/A

2(50.0%)

4Total

Phase 1(2)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06485258Phase 1Completed

CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

Role: collaborator

NCT06962904Phase 1Active Not Recruiting

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

Role: collaborator

NCT05241847Not ApplicableCompleted

Starzl Network Patient Reported Outcomes

Role: collaborator

NCT03691220Not ApplicableCompleted

Improving Medication Adherence in Adolescents Who Had a Liver Transplant

Role: collaborator

NCT00674388Recruiting

The Pediatric Anesthesia Quality Improvement Project

Role: collaborator

NCT01410305Completed

Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults

Role: collaborator

All 6 trials loaded